Azenta (AZTA) Stock Overview
Provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for AZTA from our risk checks.
AZTA Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Azenta, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$30.97 |
| 52 Week High | US$55.64 |
| 52 Week Low | US$23.91 |
| Beta | 1.62 |
| 1 Month Change | 1.67% |
| 3 Month Change | -0.61% |
| 1 Year Change | -29.84% |
| 3 Year Change | -26.12% |
| 5 Year Change | -36.38% |
| Change since IPO | 209.70% |
Recent News & Updates
Is There Now An Opportunity In Azenta, Inc. (NASDAQ:AZTA)?
Sep 12
Azenta, Inc. (NASDAQ:AZTA) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates
Aug 07Recent updates
Is There Now An Opportunity In Azenta, Inc. (NASDAQ:AZTA)?
Sep 12Azenta, Inc. (NASDAQ:AZTA) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates
Aug 07Calculating The Fair Value Of Azenta, Inc. (NASDAQ:AZTA)
Jul 24Azenta: Down 40% And Still Not Compelling
Jul 06
Pharma And Biotech Outsourcing Will Shape Future Market Dynamics
Strong industry trends and Azenta's infrastructure investments are driving above-market growth, recurring revenues, and operating leverage in sample management and biobanking.Azenta: Life Science Business Failing To Come To Life
Apr 17Azenta, Inc.'s (NASDAQ:AZTA) 29% Share Price Plunge Could Signal Some Risk
Apr 05Are Investors Undervaluing Azenta, Inc. (NASDAQ:AZTA) By 50%?
Mar 28Azenta: Taking A Pass
Jan 27At US$51.81, Is Azenta, Inc. (NASDAQ:AZTA) Worth Looking At Closely?
Jan 10A Look At The Intrinsic Value Of Azenta, Inc. (NASDAQ:AZTA)
Dec 20Analysts Have Just Cut Their Azenta, Inc. (NASDAQ:AZTA) Revenue Estimates By 14%
Nov 17Shareholders Should Be Pleased With Azenta, Inc.'s (NASDAQ:AZTA) Price
Nov 14Azenta: Life Science Play Is Not Coming To Life
Sep 11Azenta, Inc.'s (NASDAQ:AZTA) Shares May Have Run Too Fast Too Soon
Jul 19Should You Investigate Azenta, Inc. (NASDAQ:AZTA) At US$52.18?
Apr 27Shareholders Should Be Pleased With Azenta, Inc.'s (NASDAQ:AZTA) Price
Apr 05Subdued Growth No Barrier To Azenta, Inc.'s (NASDAQ:AZTA) Price
Dec 28Is There An Opportunity With Azenta, Inc.'s (NASDAQ:AZTA) 31% Undervaluation?
Nov 07At US$50.66, Is It Time To Put Azenta, Inc. (NASDAQ:AZTA) On Your Watch List?
Sep 13Shareholder Returns
| AZTA | US Life Sciences | US Market | |
|---|---|---|---|
| 7D | 3.9% | 3.0% | 1.7% |
| 1Y | -29.8% | -13.5% | 14.5% |
Return vs Industry: AZTA underperformed the US Life Sciences industry which returned -13.5% over the past year.
Return vs Market: AZTA underperformed the US Market which returned 14.5% over the past year.
Price Volatility
| AZTA volatility | |
|---|---|
| AZTA Average Weekly Movement | 8.6% |
| Life Sciences Industry Average Movement | 8.6% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in US Market | 17.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: AZTA has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: AZTA's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1978 | 3,000 | John P. Marotta | www.azenta.com |
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates through three reportable segments: Sample Management Solutions, Multiomics, and B Medical Systems. The Sample Management Solutions segment provides sample management products and solutions, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services.
Azenta, Inc. Fundamentals Summary
| AZTA fundamental statistics | |
|---|---|
| Market cap | US$1.44b |
| Earnings (TTM) | -US$167.54m |
| Revenue (TTM) | US$668.82m |
Is AZTA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AZTA income statement (TTM) | |
|---|---|
| Revenue | US$668.82m |
| Cost of Revenue | US$387.25m |
| Gross Profit | US$281.57m |
| Other Expenses | US$449.12m |
| Earnings | -US$167.54m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -3.65 |
| Gross Margin | 42.10% |
| Net Profit Margin | -25.05% |
| Debt/Equity Ratio | 0% |
How did AZTA perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/17 21:35 |
| End of Day Share Price | 2025/10/17 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/09/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Azenta, Inc. is covered by 17 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Christopher Muse | Barclays |
| Brett Hodess | BofA Global Research |
| Yuan Zhi | B. Riley Securities, Inc. |